Sentences with phrase «immunotherapy for»

Genocea's pipeline includes GEN - 003, a novel T cell - enabled immunotherapy for genital herpes currently in Phase 2 clinical development, and earlier - stage investments in immuno - oncology.

«I am excited by recent developments in immunotherapy for cancer, and I think this is an area we can use to treat osteosarcoma.»

He has also served as Director for Cancer Immunology and Immunotherapy for the Donald Monk Cancer Research Foundation; he is a partner at Veterinary Research Associates, LLC, a company focused on development and implementation of diagnostics for veterinary medicine and a founder / scientist at ApopLogic Pharmaceuticals, Inc, a biotechnology company focused on development of cancer therapeutics.

Veterinarians have used immunotherapy for over 30 years to treat pets with skin allergies (atopic dermatitis or «AD»).

Immunotherapy for Cancer.

A randomized, double - blind, placebo - controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

Compared to those on a placebo, children who received immunotherapy for about 3.5 years could eat far more egg without experiencing a reaction.

In a follow - up study, 9 of 12 children who received peanut immunotherapy for up to five years achieved tolerance.

The children received omalizumab or a placebo for eight weeks before starting immunotherapy and for eight weeks during combination treatment with immunotherapy for two to five trigger foods.

The research presentations cover a wide range of disciplines, treatment approaches and cancer types, including a unique form of immunotherapy for ovarian cancer, promising results on a new treatment approach for Hodgkin lymphoma in children and young adults and an effort to build a predictive tool to determine which patients are most likely to respond well to checkpoint inhibitors.

iTeos is focused on expanding the benefits of immunotherapy for cancer patients by developing a proprietary pipeline targeting IDO1, A2A, TIGIT immune checkpoint and non-immunogenic («cold») tumours.

If clinical trials of anti-PD-1 continue to show promising results, cancer patients may soon have access to another powerful immunotherapy for the treatment of numerous cancers, including melanoma, non-small cell lung cancer, and other solid tumors.

How Professor Doug Fearon's experiences with autoimmune disease patients contributed to the discovery of a new potential immunotherapy for cancer...

Findings from his research will be invaluable towards the development of systems immunotherapy for breast cancer.

Ipilimumab is the second active immunotherapy for cancer to be approved by the FDA, following the approval in April 2010 of sipuleucel - T (Provenge ®) for advanced castrate - resistant prostate cancer.

Another avenue of immunotherapy for breast cancer is adoptive T cell transfer.

Knowledge gained from mechanistic studies may contribute to the design of allogeneic vaccine - based or adoptive immunotherapy for breast cancer.

More than a dozen experimental clinical therapies and vaccines have been developed from research from the Weiner laboratory, including the first Zika vaccine in clinical trials, as well as a novel immunotherapy for HPV - associated cancer and precancer.

The Cancer Research Institute, a nonprofit organization dedicated to funding laboratory and clinical studies aimed at harnessing the cancer - fighting power of the immune system, has been the leader in cancer immunotherapy for 60 years.

Specificity of mechanisms for plaque removal after Ab immunotherapy for Alzheimer disease.

CRI, a US nonprofit organization that funds research internationally, has a 65 - year legacy of supporting the discovery and development of immunotherapy for all types of cancer.

Another avenue of immunotherapy for cervical cancer is adoptive T cell transfer.

Potential mechanisms such as T - cell and microglial activation may be responsible and are under consideration to develop a safer anti-Abeta immunotherapy for AD.

They were the first successful forms of immunotherapy for lymphoma, with rituximab (Rituxan), a monoclonal antibody against the CD20 target, now the standard of care for all B cell lymphomas.

The intent of the effort is to build off the identified immunologic factors that may be modulated to improve immunotherapy for CRC patients, with the goal that the biomarkers and treatment strategies identified in the manuscript will become part of the routine management of colorectal cancer (CRC).

Several approaches to immunotherapy for esophageal cancer have shown promise in early clinical trials.

Another major avenue of immunotherapy for pancreatic cancer is adoptive T cell transfer.

His contributions to the development of PD - 1 immunotherapy for Hodgkin lymphoma received the Lymphoma Hub award for best research paper in lymphoma in 2014.

This page features information on melanoma and immunotherapy for melanoma patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with melanoma.

One promising and active immunotherapy for childhood cancer is adoptive T cell transfer.

Another major avenue of immunotherapy for melanoma is adoptive cell therapy.

These studies will help us understand the mechanisms by which MAIT cells interact with liver tissue during cancer development, which could lead to the potential for an immunotherapy for liver cancer.

Several approaches to immunotherapy for pancreatic cancer have shown promise in early clinical trials.

Another major avenue of immunotherapy for head and neck cancer is adoptive T cell transfer.

This year brought a series of milestones in immunotherapy for Merkel cell carcinoma — a rare and deadly skin cancer — by Drs. Paul Nghiem, Kelly Paulson and colleagues:

Another major avenue of immunotherapy for prostate cancer is adoptive cell therapy.

Based in Gosselies, Belgium, iTeos, a spin - off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL), is focused on expanding the benefits of immunotherapy for cancer patients.

Pathways towards an effective immunotherapy for Parkinson's disease.

«Not only does this research provide compelling evidence for further investigation of immunotherapy for treating stomach cancer, it also provides the first model for preclinical testing of these treatments.»

DENVER — Despite very encouraging progress in the development and use of immunotherapy for patients with non-small cell lung cancer, much confusion remains regarding patient selection for each therapy.

Both recent experience with immunotherapy for clearance of Aβ in AD, and their own (and Prothena's) experience with AS - clearing immunotherapies in animal models, indicate that in order to be effective as disease - modifying agents when administered alone, therapies that remove proteinaceous aggregates from the brain must be initiated in the early clinical or even preclinical stages of the disease, before the burden of other forms of aging damage becomes entrenched.

The medication is already being successfully used as immunotherapy for advanced melanoma — a comparatively rare type of cancer.

That may be why immunotherapy for narcolepsy has so far yielded lackluster results.

As of this writing, immunotherapy for kidney cancer has been approved for second - line kidney cancer treatment only.

Scientists have studied immunotherapy for decades but have had trouble making it work; the immune system seemed unable to see the cancer as foreign or inexplicably refrained from attacking malignancies.

What is immunotherapy for lung cancer and how does it work?

Another major avenue of immunotherapy for multiple myeloma is adoptive cell transfer.

Biernacki's research focuses on developing targeted immunotherapy for pediatric acute myeloid leukemia, or AML.

This approach has the potential to provide a novel immunotherapy for women with ovarian cancer.

Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers Drug Discovery & Development — May 14, 2015